DCAT Week
Rentschler Biopharma Taps Robert Panting as VP of Global CPM and Strategy
Panting will be responsible for developing and driving a unified strategic roadmap.
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed Robert Panting, Ph.D., to the newly created position of Vice President, Global Client Program Management (CPM) and Strategy, effective immediately.
In this role, Panting will lead the company’s global Strategy initiatives and CPM functions and will report directly to the CEO, serving as a member of the Global Leadership Team.
“With increasing complexity in drug development and manufacturing, having a strong, integrated global strategic framework is key,” said Benedikt von Braunmühl, CEO of Rentschler Biopharma. “Rob brings extensive experience in leading complex projects and aligning cross-functional teams, making him the ideal choice for this role. His leadership will be instrumental in strengthening our ability to deliver exceptional value to our clients while keeping our corporate strategy at the heart of our operations.”
Experience
Panting joined Rentschler Biopharma in 2021 as General Manager of Rentschler ATMP Ltd., where he led the establishment of a Center of Excellence for Cell and Gene Therapy. Following a strategic realignment of Rentschler Biopharma’s global business operations, he transitioned into this new leadership role to drive global strategic execution.
Before joining the company, Panting spent ten years at Fujifilm Diosynth Biotechnologies in positions of increasing responsibility in project management, client management and business planning. In his last role as vice President for Program Management and Sales & Operations Planning, he focused on client project delivery, strategic planning, and leading major infrastructure and organizational initiatives.
“I am honored to take on this role and drive our unified, forward-thinking approach that ensures continued success for our global clients,” said Panting. “By integrating corporate strategy with client program management, we will enhance alignment across key functions, leverage synergies, and enable strategic initiatives that improve efficiency and client-centric execution, ensuring life-saving therapies reach the market successfully.”
